Literature DB >> 15849640

[Surgical therapy of unspecific and specific Spondylodiscitis].

T Lerner1, L Hackenberg, S Rösler, U Joosten, H Halm, U Liljenqvist.   

Abstract

AIM: The aim of this study was to evaluate the clinical and radiological results of surgical treatment of thoracic and lumbar vertebral osteomyelitis by means of one-stage extrafocal posterior stabilisation, anterior debridement, and anterior column reconstruction.
METHOD: A retrospective analysis of the peri- and postoperative parameters of 62 patients with a clinical and radiographic follow-up of 2.6 years that were available for 46 patients was performed. In 42 cases, the anterior column was restored with structural bone grafts, in 20 patients, expandable titanium cages filled with morsellised autologous bone and antibiotic collagen sponges were used. To assess the course of spinal alignment a radiometric analysis was undertaken. Furthermore, the Roland-Morris score (RMS) was applied to evaluate the back pain-related disability.
RESULTS: The diagnosis was made no earlier than 2.7 months after the first symptoms. Preoperatively, 40 % of the patients presented with neurological impairment, of these 76 % improved after surgery. Staphylococcus aureus was the most common pathogen isolated (32 %), Mycobacterium tuberculosis was found in 11 % of the patients. Except for one patient with revision for persistent infection and consecutive failure of the bone graft, primary eradication of the infection was achieved in all cases. At follow-up, bony fusion was radiographically observed in all patients. When using cages, the segmental loss of correction was significantly lower than when using bone grafts (1.0 vs. 4.1 degrees ). At follow-up the RMS averaged 6.6.
CONCLUSION: One-stage extrafocal posterior stabilisation combined with anterior debridement and anterior column reconstruction with bone grafts or titanium cages is a safe and effective strategy for patients with vertebral osteomyelitis in need of surgery. Titanium cages have proven to be biomechanically advantageous, especially in cases of extensive destruction and are not associated with higher rates of persistence or recurrence of infection compared to autologous bone grafts.

Entities:  

Mesh:

Year:  2005        PMID: 15849640     DOI: 10.1055/s-2005-836455

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  15 in total

Review 1.  Treatment of spondylodiscitis.

Authors:  Kourosh Zarghooni; Marc Röllinghoff; Rolf Sobottke; Peer Eysel
Journal:  Int Orthop       Date:  2011-12-06       Impact factor: 3.075

2.  [Collagen hydroxyapatite (Healos) saturated with gentamicin or levofloxacin. In vitro antimicrobial effectiveness - a pilot study].

Authors:  C H Fürstenberg; B Wiedenhöfer; C Putz; I Burckhardt; S Gantz; K Kleinschmidt; K Schröder
Journal:  Orthopade       Date:  2010-04       Impact factor: 1.087

3.  [Therapy of unspecific destructive spondylodiscitis with special consideration to sagittal alignment].

Authors:  C Klöckner; B Wiedenhöfer
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

4.  Spondylodiscitis severity code: scoring system for the classification and treatment of non-specific spondylodiscitis.

Authors:  L Homagk; N Homagk; J R Klauss; K Roehl; G O Hofmann; D Marmelstein
Journal:  Eur Spine J       Date:  2015-04-21       Impact factor: 3.134

5.  Complex 360°-reconstruction and stabilization of the cervical spine due to osteomyelitis.

Authors:  Martin Strowitzki; Jan Vastmans; Matthias Vogel; Hans Jaksche
Journal:  Eur Spine J       Date:  2010-12-01       Impact factor: 3.134

6.  [Pyogenic spondylodiscitis of the thoracic and lumbar spine : a new classification and guide for surgical decision-making].

Authors:  M Akbar; B Lehner; S Doustdar; C H Fürstenberg; S Hemmer; T Bruckner; C Carstens; B Wiedenhöfer
Journal:  Orthopade       Date:  2011-07       Impact factor: 1.087

7.  Current diagnosis and treatment of spondylodiscitis.

Authors:  Rolf Sobottke; Harald Seifert; Gerd Fätkenheuer; Matthias Schmidt; Axel Gossmann; Peer Eysel
Journal:  Dtsch Arztebl Int       Date:  2008-03-07       Impact factor: 5.594

8.  Distribution of HIV-1 in the genomes of AIDS patients.

Authors:  L Tsyba; A V Rynditch; E Boeri; K Jabbari; G Bernardi
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

9.  [Specific spondylitis].

Authors:  V Bullmann; U R Liljenqvist; M Koriller; T Lange
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

10.  [Gold standard for implant selection in operative therapy of spondylitis/spondylodiscitis].

Authors:  B Wiedenhöfer; S Hemmer; M Akbar; B Lehner; G Schmidmaier; C Klöckner
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.